
President Donald Trump announced Thursday a new initiative called "TrumpRx" aimed at lowering the cost of popular weight-loss drugs Wegovy and Zepbound, in deals with pharmaceutical companies Novo Nordisk and Eli Lilly.
The program seeks to make these treatments more affordable for millions of Americans struggling with obesity.